Genzyme

Random entry RSS

Posted in:
Legal

Immunex Loses Battle Over Institution of Follow-on IPR Petitions
By Andrew Storaska and Jennifer P. Nock March 23, 2018 Comments are off
Sanofi-Aventis U.S. LLC, Genzyme Corporation, and Regeneron Pharmaceuticals, Inc. recently scored a victory in their ongoing dispute over a...

Read more

Tagged with: District Court, Dupixent®, Follow-on petitions, Genzyme, Immunex, IPR, PTAB, Regeneron, Sanofi

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:
Legal

Sanofi, Genzyme, and Regeneron Voluntarily Dismiss Dupixent® (Dupilumab) Declaratory Judgment Suit in Massachusetts
By Seth Cockrum and C. Nichole Gifford May 8, 2017 Comments are off
The battle over the proper forum for patent infringement litigation regarding Dupixent® (Dupilumab) appears to have been resolved. Last...

Read more

Tagged with: Amgen, District Court, dupilumab, Dupixent®, Genzyme, Immunex, IPR, Legal, Litigation, PTAB, Regeneron, Sanofi, USPTO

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top